ZOLEDRO-DENK 4MG/5ML VIAL1X5ML

Zoledro-Denk (Zoledronic Acid) is a bisphosphonate medication primarily used for the treatment and prevention of osteoporosis in postmenopausal women and men at high risk of fractures. It is also indicated for the treatment of Paget’s disease of bone, a condition that causes abnormal bone remodeling. Additionally, Zoledronic Acid is utilized in the management of hypercalcemia of malignancy and to prevent skeletal-related events in patients with bone metastases from solid tumors. The drug works by inhibiting osteoclast-mediated bone resorption, thereby increasing bone mineral density and reducing the risk of fractures. It is administered as an intravenous infusion, typically once a year for osteoporosis or more frequently for other indications. Common side effects may include flu-like symptoms, fever, and potential renal impairment, necessitating monitoring of kidney function before administration.